APA (7th ed.) Citation

B, B., T, C., R, G., E, A., S, K., H, A., . . . HT, T. (2024). Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics. Archives of gerontology and geriatrics, 125, 105517. https://doi.org/10.1016/j.archger.2024.105517

Chicago Style (17th ed.) Citation

B, Baba, Ceylani T, Gurbanov R, Acikgoz E, Keskin S, Allahverdi H, Samgane G, Tombuloglu H, and Teker HT. "Promoting Longevity in Aged Liver Through NLRP3 Inflammasome Inhibition Using Tauroursodeoxycholic Acid (TUDCA) and SCD Probiotics." Archives of Gerontology and Geriatrics 125 (2024): 105517. https://doi.org/10.1016/j.archger.2024.105517.

MLA (9th ed.) Citation

B, Baba, et al. "Promoting Longevity in Aged Liver Through NLRP3 Inflammasome Inhibition Using Tauroursodeoxycholic Acid (TUDCA) and SCD Probiotics." Archives of Gerontology and Geriatrics, vol. 125, 2024, p. 105517, https://doi.org/10.1016/j.archger.2024.105517.